NCT07293702 IASTM Effects on Pain, Functionality, and Proprioception in Subacromial Impingement
| NCT ID | NCT07293702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Medipol University Hospital |
| Condition | Subacromial Impingement Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2026-01-25 |
| Primary Completion | 2026-05-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2026-01-25 with a primary completion date of 2026-05-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study will be to investigate the effects of Instrument-Assisted Soft Tissue Mobilization (IASTM), applied in addition to a conventional exercise program, on pain, range of motion, proprioception, functionality, and quality of life in individuals with Subacromial Impingement Syndrome (SIS).
Eligibility Criteria
Inclusion Criteria: * Individuals diagnosed with SIS by MRI * Men and women between 40 and 60 years of age * Individuals with symptoms persisting for at least one month * Individuals with a minimum of 60° of shoulder flexion and abduction range of motion Exclusion Criteria: * Individuals with a history of surgery on the affected arm * Individuals with an open wound on the arm * Individuals with an active infection * Individuals with inflammatory joint disease * Individuals with malignant or benign tumors were excluded from the study.
Contact & Investigator
Burak Menek, PhD
PRINCIPAL INVESTIGATOR
Medipol University
Frequently Asked Questions
Who can join the NCT07293702 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Subacromial Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07293702 currently recruiting?
Yes, NCT07293702 is actively recruiting participants. Contact the research team at bmenek@medipol.edu.tr for enrollment information.
Where is the NCT07293702 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07293702 clinical trial?
NCT07293702 is sponsored by Istanbul Medipol University Hospital. The principal investigator is Burak Menek, PhD at Medipol University. The trial plans to enroll 38 participants.